These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 30880695)

  • 1. Characterization of
    Shahid I; Almalki WH; Ibrahim MM; Alghamdi SA; Mukhtar MH; Almalki SSR; Alkahtani SA; Alhaidari MS
    Indian J Med Microbiol; 2018; 36(4):494-503. PubMed ID: 30880695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro inhibitory analysis of consensus siRNAs against NS3 gene of hepatitis C virus 1a genotype.
    Shahid I; AlMalki WH; AlRabia MW; Mukhtar MH; Almalki SSR; Alkahtani SA; Ashgar SS; Faidah HS; Hafeez MH
    Asian Pac J Trop Med; 2017 Jul; 10(7):701-709. PubMed ID: 28870347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stable Huh-7 cell lines expressing non-structural proteins of genotype 1a of hepatitis C virus.
    Shahid I; Gull S; Ijaz B; Ahmad W; Ansar M; Asad S; Kausar H; Sarwar MT; Khan MK; Hassan S
    J Virol Methods; 2013 Apr; 189(1):65-9. PubMed ID: 23352716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral therapy: inhibition of Hepatitis C Virus expression by RNA interference directed against the NS5B region of the viral genome.
    Trejo-Avila L; Elizondo-González R; Trujillo-Murillo Kdel C; Zapata-Benavides P; Rodríguez-Padilla C; Rivas-Estilla AM
    Ann Hepatol; 2007; 6(3):174-80. PubMed ID: 17786145
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic potential of Taraxacum officinale against HCV NS5B polymerase: In-vitro and In silico study.
    Rehman S; Ijaz B; Fatima N; Muhammad SA; Riazuddin S
    Biomed Pharmacother; 2016 Oct; 83():881-891. PubMed ID: 27513212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfection and expression of HCV-NS5B gene in Huh-7 cells.
    Fang J; Ouyang E; Wu CH; Wu GY; Qiu D; Xiao S
    Chin Med J (Engl); 2000 Jul; 113(7):602-5. PubMed ID: 11776027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro efficacy of approved and experimental antivirals against novel genotype 3 hepatitis C virus subgenomic replicons.
    Yu M; Corsa AC; Xu S; Peng B; Gong R; Lee YJ; Chan K; Mo H; Delaney W; Cheng G
    Antiviral Res; 2013 Nov; 100(2):439-45. PubMed ID: 24013001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-transcriptional inhibition of hepatitis C virus replication through small interference RNA.
    Ali Ashfaq U; Ansar M; Sarwar MT; Javed T; Rehman S; Riazuddin S
    Virol J; 2011 Mar; 8():112. PubMed ID: 21388559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor.
    Chen Y; Bopda-Waffo A; Basu A; Krishnan R; Silberstein E; Taylor DR; Talele TT; Arora P; Kaushik-Basu N
    Antivir Chem Chemother; 2009 Sep; 20(1):19-36. PubMed ID: 19794229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ribonucleotide reductase M2 promotes RNA replication of hepatitis C virus by protecting NS5B protein from hPLIC1-dependent proteasomal degradation.
    Kitab B; Satoh M; Ohmori Y; Munakata T; Sudoh M; Kohara M; Tsukiyama-Kohara K
    J Biol Chem; 2019 Apr; 294(15):5759-5773. PubMed ID: 30755480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
    Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
    J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV Genotype 6a Escape From and Resistance to Velpatasvir, Pibrentasvir, and Sofosbuvir in Robust Infectious Cell Culture Models.
    Pham LV; Ramirez S; Gottwein JM; Fahnøe U; Li YP; Pedersen J; Bukh J
    Gastroenterology; 2018 Jun; 154(8):2194-2208.e12. PubMed ID: 29454794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.
    Khaliq S; Jahan S; Pervaiz A; Ali Ashfaq U; Hassan S
    Virol J; 2011 May; 8():221. PubMed ID: 21569449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized, placebo-controlled, single-ascending-dose study of BMS-791325, a hepatitis C virus (HCV) NS5B polymerase inhibitor, in HCV genotype 1 infection.
    Sims KD; Lemm J; Eley T; Liu M; Berglind A; Sherman D; Lawitz E; Vutikullird AB; Tebas P; Gao M; Pasquinelli C; Grasela DM
    Antimicrob Agents Chemother; 2014 Jun; 58(6):3496-503. PubMed ID: 24733462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Site-specific cleavage of HCV genomic RNA and its cloned core and NS5B genes by DNAzyme.
    Kumar D; Chaudhury I; Kar P; Das RH
    J Gastroenterol Hepatol; 2009 May; 24(5):872-8. PubMed ID: 19220662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative approaches for efficient inhibition of hepatitis C virus RNA replication by small interfering RNAs.
    Krönke J; Kittler R; Buchholz F; Windisch MP; Pietschmann T; Bartenschlager R; Frese M
    J Virol; 2004 Apr; 78(7):3436-46. PubMed ID: 15016866
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations in NS5B polymerase of hepatitis C virus: impacts on in vitro enzymatic activity and viral RNA replication in the subgenomic replicon cell culture.
    Cheney IW; Naim S; Lai VC; Dempsey S; Bellows D; Walker MP; Shim JH; Horscroft N; Hong Z; Zhong W
    Virology; 2002 Jun; 297(2):298-306. PubMed ID: 12083828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479.
    Ali S; Leveque V; Le Pogam S; Ma H; Philipp F; Inocencio N; Smith M; Alker A; Kang H; Najera I; Klumpp K; Symons J; Cammack N; Jiang WR
    Antimicrob Agents Chemother; 2008 Dec; 52(12):4356-69. PubMed ID: 18838588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of hepatitis C virus replicon by RNA interference directed against the NS3 and NS5B regions of the viral genome.
    Takigawa Y; Nagano-Fujii M; Deng L; Hidajat R; Tanaka M; Mizuta H; Hotta H
    Microbiol Immunol; 2004; 48(8):591-8. PubMed ID: 15322339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.